2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Infectious Disease Diagnostics Testing Market?
The infectious disease diagnostic testing market is projected to experience substantial growth owing to the anticipated increase in respiratory infections. These infections target the respiratory system, which includes the nose, throat, airways, and lungs. The escalation in respiratory infections can be attributed to viral and bacterial transmission due to close interaction with infected people, unsanitary habits, congested living conditions, and seasonal changes in weather. It is critical to diagnose and treat respiratory infections promptly, which is where infectious disease diagnostic testing plays a crucial role, accurately identifying bacteria and viruses in patient specimens. For instance, the Canadian Institute for Health Information reported in February 2024 that acute upper respiratory infection-related hospitalisations had surged by 32% from 2,114 cases in 2022 to 2,797 instances in 2023. Consequently, this increase in respiratory infections fuels the expansion of the infectious disease diagnostic testing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
#What Growth Opportunities Will Drive the Infectious Disease Diagnostics Testing Market’s CAGR Through 2034?
In recent times, there has been a swift expansion in the size of the infectious disease diagnostics testing market. From $38.52 billion in 2024, this market is projected to escalate to $42.56 billion in 2025 with a compound annual growth rate (CAGR) of 10.5%. The surge during the historic period is linked to the escalating instances of disease outbreaks like SARS, Ebola, and Zika, heightened awareness of the significance of early identification and prevention of infectious illnesses among healthcare practitioners and the public, an upsurge in disease monitoring, control and prevention programs funded by the government, growing global commerce and travel facilitating the transmission of infectious diseases, and amplified healthcare expenditure, particularly in the burgeoning economies.
The market for diagnostic testing for infectious diseases is poised for swift expansion in the coming years, with an estimated value of $62.58 billion by 2029, reflecting a compound annual growth rate (CAGR) of 10.1%. Factors fuelling this projected growth can be traced back to the constant introduction of new pathogens, including fresh variants of influenza or COVID-19, the shift toward individualized medicine and targeted treatments, an uptick in demand for fast and local testing solutions, an increased emphasis on early detection systems and epidemiological surveillance as well as heightened research and development activity aimed at innovating diagnostic technologies and biomarkers. Key trends to watch out for during this forecast period include the miniaturization and mobility of diagnostic devices, the use of multiplex assays capable of identifying multiple pathogens at once, the incorporation of digital health solutions like mobile applications and telemedicine platforms, the rising application of next-generation sequencing (NGS) technologies in diagnosing infectious diseases, advancements in biosensor technologies enabling quick and sensitive detection of infectious agents, and the integration of AI and machine learning algorithms into diagnostic platforms.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15831
What Are the Key Market Innovations in theInfectious Disease Diagnostics Testing Market Over the Coming Years?
Leading firms in the infectious disease diagnostic testing market are shifting their focus towards the creation of cutting-edge technologies like molecular diagnostics platforms to maintain their market stance. These molecular diagnostics platforms are advanced systems made to identify and analyze nucleic acids (either DNA or RNA) from biological samples for diagnostic objectives. For instance, a US-based medical technology corporation known as Becton Dickinson and Company introduced the BD COR System, a completely automated high-efficiency infectious disease molecular diagnostics platform, in May 2022. This platform seamlessly integrates and automates the full molecular laboratory procedure from sample handling to diagnostic results, removing the requirement for manual sample sorting and liberating lab specialists for more complex tasks. This system has the capacity to handle up to 1,700 samples and provide results in less than 24 hours, providing high-efficiency capabilities and sophisticated genotyping for diseases like HPV and STIs.
Who Are the Top Companies Driving Innovation and Growth in theInfectious Disease Diagnostics Testing Market?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Infectious Disease Diagnostics Testing Market and Drive Its Revenue Growth?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp
Which Regions Are Emerging as Leaders in the Infectious Disease Diagnostics Testing Market?
North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2025, By The Business Research Company:
PCR And Realtime PCR Testing Global Market Opportunities And Strategies To 2030: COVID-19 Implication And Growth
https://www.thebusinessresearchcompany.com/report/pcr-and-rt-pcr-testing
Pharmaceutical Sterility Testing Global Market Report 2024
Prenatal Testing & Newborn Screening Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
